Posterior reversible encephalopathy syndrome: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
**[[CVA]] | **[[CVA]] | ||
**[[Intracranial Hemorrhage]] | **[[Intracranial Hemorrhage]] | ||
** | **[[Cerebral Venous Thrombosis]] | ||
*Infectious | *Infectious | ||
**[[Encephalitis]] | **[[Encephalitis]] | ||
| Line 29: | Line 29: | ||
**[[Systemic Lupus Erythematosus|SLE]] | **[[Systemic Lupus Erythematosus|SLE]] | ||
*Psychiatric disorder | *Psychiatric disorder | ||
==Workup== | ==Workup== | ||
*Focus on [[Altered Mental Status#Work-Up|AMS workup]], with PRES as diagnosis of exclusion | *Focus on [[Altered Mental Status#Work-Up|AMS workup]], with PRES as diagnosis of exclusion | ||
Revision as of 23:12, 24 April 2015
Background
- Caused by:
- Hypertensive Encephalopathy
- Immunosuppresion
- Uremia with HTN
- Newly recognized, described in 1996[1]
Clinical Presentation [2]
- Seizures
- Hypertension
- Encephalopathy/Altered Mental Status
- Visual Disturbances
- Vomiting
- Headache
Differential Diagnosis[3]
- Eclampsia
- Vascular
- Infectious
- Metabolic
- Hepatic Encephalopathy
- Hyponatremia
- Porphyria
- Demyelinating Disorders
- Psychiatric disorder
Workup
- Focus on AMS workup, with PRES as diagnosis of exclusion
Diagnosis
- MRI shows cerebral edema, especially in posterior circulation[3]
Management
- Control Blood Pressure
- Discontinue Immunosupprants
Disposition
- Admit
NB - Cardiac Transplant patients are at high risk, with relative hypertension and on immunosuppressants
See Also
References
- ↑ Hinchey J, et al. "A reversible posterior leukoencephalopathy syndrome". PMID 8559202
- ↑ Staykov D. "Posterior reversible encephalopathy syndrome". PMID 21257628
- ↑ 3.0 3.1 Garg RK (January 2001). "Posterior leukoencephalopathy syndrome". Postgrad Med J 77 (903): 24–8. doi:10.1136/pmj.77.903.24. PMC 1741870. PMID 11123390